Chalazion Treatment: A Concise Review of Clinical Trials

Curr Eye Res. 2023 Nov 8:1-10. doi: 10.1080/02713683.2023.2279014. Online ahead of print.ABSTRACTA chalazion is one of the most common eye conditions presenting as a mass lesion of the eyelids. It is seen in all age groups. Chalazion is a non-inflammatory process and develops due to retained secretion of the meibomian or Zeis glands. Treatment of choice differs among clinicians and may include application of warm compress onto eyelids, lid hygiene, using local antibiotic ointment with or without steroids, injecting steroid solution (triamcinolone acetonide) into the lesion and surgical removal of the lesion by incision and curettage. In addition, there are some other experimented methods such as injection of botulinum toxin A, tarsal trephination, removal of chalazion by application of CO2 laser or cryogenic action. However, there is currently no commonly agreed treatment of choice. In this review, we aimed to summarize findings from clinical trials and hopefully, identify a treatment of choice in chalazion.PMID:37937798 | DOI:10.1080/02713683.2023.2279014
Source: Current Eye Research - Category: Opthalmology Authors: Source Type: research